Avalo Therapeutics Inc (AVTX)
11.10
+1.51
(+15.75%)
USD |
NASDAQ |
May 20, 16:00
10.85
-0.25
(-2.25%)
After-Hours: 20:00
Avalo Therapeutics Free Cash Flow: -26.83M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
March 31, 2024 | -26.83M |
December 31, 2023 | -30.68M |
September 30, 2023 | -31.85M |
June 30, 2023 | -19.29M |
March 31, 2023 | -20.74M |
December 31, 2022 | -26.85M |
September 30, 2022 | -40.02M |
June 30, 2022 | -62.07M |
March 31, 2022 | -68.74M |
December 31, 2021 | -71.00M |
September 30, 2021 | -68.27M |
June 30, 2021 | -63.83M |
March 31, 2021 | -53.20M |
December 31, 2020 | -40.60M |
September 30, 2020 | -27.91M |
June 30, 2020 | -23.59M |
March 31, 2020 | -21.85M |
December 31, 2019 | -19.40M |
September 30, 2019 | -20.19M |
Date | Value |
---|---|
June 30, 2019 | -13.15M |
March 31, 2019 | -6.680M |
December 31, 2018 | -3.692M |
September 30, 2018 | -3.782M |
June 30, 2018 | 15.91M |
March 31, 2018 | 14.49M |
December 31, 2017 | 12.56M |
September 30, 2017 | 11.40M |
June 30, 2017 | -11.16M |
March 31, 2017 | -13.13M |
December 31, 2016 | -14.61M |
September 30, 2016 | -14.43M |
June 30, 2016 | -12.83M |
March 31, 2016 | -10.83M |
December 31, 2015 | -10.18M |
September 30, 2015 | -10.60M |
June 30, 2015 | -15.89M |
March 31, 2015 | -16.38M |
December 31, 2014 | -15.52M |
Free Cash Flow Range, Past 5 Years
-71.00M
Minimum
Dec 2021
-13.15M
Maximum
Jun 2019
-37.50M
Average
-29.29M
Median
Free Cash Flow Benchmarks
Imunon Inc | -21.32M |
iBio Inc | -18.67M |
Kodiak Sciences Inc | -175.76M |
Petros Pharmaceuticals Inc | -8.013M |
Ocugen Inc | -65.62M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -6.202M |
Cash from Investing (Quarterly) | 0.356M |
Cash from Financing (Quarterly) | 108.61M |
Free Cash Flow Per Share (Quarterly) | -7.217 |
Free Cash Flow Yield | -505.1% |